Intraperitoneal therapy for stage III ovarian cancer: a therapy whose time has come!

J Clin Oncol. 2002 Oct 1;20(19):3944-6. doi: 10.1200/JCO.2002.20.19.3944.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Clinical Trials, Phase III as Topic
  • Female
  • Humans
  • Infusions, Parenteral
  • Neoplasm Staging
  • Ovarian Neoplasms / drug therapy*
  • Survival Analysis

Substances

  • Antineoplastic Agents